The new version of the medical insurance catalog has been released recently, and the pharmaceutical sector has caused another wave. Standing at the current point in time, how to grasp the investment opportunities in the pharmaceutical sector? Judging from what the reporter knows, a large number of imported original drugs have entered medical insurance by exchanging price for volume, which has intensified competition in the domestic pharmaceutical market. The institution believes that in the environment of price reduction pressure and a sharp decline in gross profit margin, cost control is very important. Raw material preparation companies have ushered in the layout opportunities, and some raw material companies have been sought after by the market recently.

According to statistics from the Price Supervision Competition Bureau of the National Development and Reform Commission, my country can produce more than 1,500 raw materials, with a total output of one million tons and an export volume of more than 60%. It has become the world's second largest raw materials producer and largest export country after the United States.

As an important part of my country's pharmaceutical industry, chemical raw materials have developed rapidly, and the industry's sales revenue and total profit continue to remain on the upward channel, with the growth trend unabated. The chemical raw materials industry has been continuously upgraded, and its products have shifted from mid- and low-end to mid- and high-end, and its R&D level has been greatly improved, and its prospects have continued to improve.

On January 6, Shanghai Sunshine Pharmaceutical Procurement Network issued the "Notice on Announcement of the First-Year Agreement Procurement Quantity of National Centralized Drug Procurement (Insulin Special Project). The notice stipulates that the results of this insulin special procurement w...

1. Construction project name and summaryProject name: Yichang Tianren Pharmaceutical Co., Ltd.'s new product types projectConstruction unit: Yichang Tianren Pharmaceutical Co., Ltd.Construction location: No. 509, Donglin Road, Yichang District, China (Hubei) Free Trade ZoneConstruction nature: e...

Chemical raw materials are various substances prepared by chemical synthesis, plant extraction or biotechnology for pharmaceutical use, but patients cannot take it directly. The drug processing in the powder, crystallization, extract state is made into a drug delivery form (such as tablets, capsules, injections, pills, ointments, etc.) that is convenient for patients to take. These drug delivery forms are called dosage forms of drugs.

On December 8, the State Food and Drug Administration approved the registration application for Tengsheng Huachuang Pharmaceutical Technology (Beijing) Co., Ltd.'s new coronavirus neutralizing antibody combination therapy drug Ambavizumab injection (BRII-196) and Romisvizumab injection (BRII-198...

Disclosure of information on environmental prevention and control of hazardous waste pollution in 2020

The antiviral product Abidor hydrochloride has played a good role in the fight against the epidemic and has been widely recognized by medical institutions. It is expected to become the main drug for the treatment of influenza A, abortion B and coronaviruses, and become a new growth point for the company.